• Latest Posts

STALICLA signs agreement with Novartis on neurodevelopmental disorders

Watch: IRLAB CEO Richard Godfrey

Alchemab Therapeutics receives £1.7M grant to work on therapy for Huntington’s disease

Charcot-Marie-Tooth study to get $250K grant

EMA gives Myrtelle’s Canavan disease gene therapy candidate OD designation 

PrecisionLife to work on R&D with Ono Pharmaceutical


bit.bio expands portfolio for drug discovery in neurodegenerative and neurological diseases

Beyond Biotech podcast 23: World Antimicrobial Awareness Week, PsychoGenics

More News! 14 Nov 2022

Minoryx and Neuraxpharm form alliance to get rights to new therapy for rare CNS disease

Minoryx and Neuraxpharm announce license agreement to further X-ALD treatment

More News! 9 Nov 2022

PrecisionLife supports Sosei Heptares to treat chronic diseases in more personalized way

Alkermes to separate oncology business